Breaking News Instant updates and real-time market news.

SU

Suncor

$31.38

-0.63 (-1.97%)

, RHHBY

Roche

$0.00

(0.00%)

10:09
01/28/19
01/28
10:09
01/28/19
10:09

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Suncor (SU) initiated with a Neutral at Credit Suisse. 2. Roche (RHHBY) initiated with a Buy at Argus. 3. Dell Technologies (DELL) initiated with an Outperform at RBC Capital. 4. Pareteum (TEUM) initiated with a Buy at Craig-Hallum. 5. PolarityTE (PTE) initiated with a Sell at National Securities while being initiated with an Outperform at Northland. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

SU

Suncor

$31.38

-0.63 (-1.97%)

RHHBY

Roche

$0.00

(0.00%)

DELL

Dell Technologies

$45.80

-0.08 (-0.17%)

TEUM

Pareteum

$2.37

0.05 (2.16%)

PTE

PolarityTE

$17.03

0.03 (0.18%)

  • 28

    Jan

  • 29

    Jan

  • 30

    Jan

  • 30

    Jan

  • 01

    Feb

  • 26

    Feb

  • 18

    Mar

SU Suncor
$31.38

-0.63 (-1.97%)

01/28/19
FBCO
01/28/19
INITIATION
Target $48
FBCO
Neutral
Suncor initiated with a Neutral at Credit Suisse
Credit Suisse analyst Manav Gupta started coverage of Suncor (SU) with a Neutral rating and $48 price target. Given the quality of assets and the management team, the analyst believes the 2.0 times valuation premium is justified, but thinks there will be a crude beta rebound in which peers Cenovus Energy (CVE) and Canadian Natural (CNQ) would outperform the more diversified and stable Suncor.
12/13/18
MITR
12/13/18
DOWNGRADE
MITR
Hold
Suncor downgraded to Hold from Buy at GMP Securities
GMP Securities analyst Michael Dunn downgraded Suncor to Hold from Buy.
12/04/18
MACQ
12/04/18
DOWNGRADE
MACQ
Neutral
Suncor downgraded to Neutral from Outperform at Macquarie
10/22/18
GARP
10/22/18
UPGRADE
GARP
Buy
Suncor upgraded to Buy from Neutral at Garp Research
RHHBY Roche
$0.00

(0.00%)

01/28/19
ARGS
01/28/19
INITIATION
Target $40
ARGS
Buy
Roche initiated with a Buy at Argus
Argus analyst John Staszak initiated Roche with a Buy rating and a price target of $40, saying that while some of the company's strong "blockbuster" products are maturing or facing competition from biosimilars, the pipeline of its new programs should support revenues. The analyst is also positive on the company's focus of tailoring treatments to patients by combining its expertise in pharmaceuticals and diagnostics. Staszak expects the sales momentum of Roche to generate "above-industry-average EPS growth over the next two years," adding that his implied price target assumes higher valuation multiples and improved earnings.
12/20/18
PIPR
12/20/18
NO CHANGE
Target $400
PIPR
Overweight
Survey shows 'solid fundamentals' for Biogen MS franchise, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Biogen (BIIB) with a $400 price target after surveying 100 neurologists. The survey feedback shows "solid fundamentals" for the company's multiple sclerosis portfolio, Raymond tells investors in a research note. He admits, however, that many investors are preoccupied with Tecfidera's intellectual property situation. Nonetheless, neurologists reported meaningful share gains for Tecfidera and Tysabri this quarter, says the analyst. Raymond believes worries over the impact to Biogen's multiple sclerosis franchise from Roche's (RHHBY) Ocrevus launch "may be behind us."
01/28/19
FBCO
01/28/19
UPGRADE
FBCO
Neutral
Roche upgraded to Neutral from Underperform at Credit Suisse
01/02/19
JPMS
01/02/19
NO CHANGE
JPMS
JPMorgan adds Novo Nordisk to Analyst Focus List, removes Roche
JPMorgan analyst Richard Vosser added Novo Nordisk (NVO) to his firm's European Analyst Focus List while removing Roche (RHHBY).
DELL Dell Technologies
$45.80

-0.08 (-0.17%)

01/16/19
01/16/19
INITIATION
Target $49

Equal Weight
Morgan Stanley starts Dell Technologies at Equal Weight with $49 target
As previously reported, Morgan Stanley analyst Katy Huberty initiated Dell Technologies with an Equal Weight rating and a price target of $49, stating that the company is well positioned to capitalize on the next 10 year technology investment cycle, which she calls the "Data Era," but she sees near-term risks, including slower hardware growth in 2019 and high leverage. Huberty also downgraded her IT Hardware industry view to In-Line from Attractive this morning, noting that the firm's recent CIO and VAR surveys provide new data points that suggest IT hardware growth will slow in 2019.Target $49.
01/23/19
01/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Dell Technologies (DELL) initiated with a Buy at Citi. 2. General Mills (GIS) and Mondelez (MDLZ) were initiated with a Buy at Guggenheim, while Kraft Heinz (KHC) and Kellogg (K) were initiated with a Neutral, and J.M. Smucker (SJM) was initiated with a Sell. 3. BRT Apartments (BRT) initiated with a Neutral at Compass Point. 4. Atara Biotherapeutics (ATRA) initiated with a Buy at Mizuho. 5. Weyerhaeuser (WY) initiated with a Buy at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/28/19
RBCM
01/28/19
INITIATION
Target $56
RBCM
Outperform
Dell Technologies initiated with an Outperform at RBC Capital
RBC Capital analyst Amit Daryanani initiated Dell Technologies with an Outperform rating and a price target of $56. The analyst cites the company's "attractive enterprise portfolio across Core, Edge, and Cloud", as well as its compelling valuation of 7.4-times his expected FY19 enterprise value to EBITDA relative to the peer group average around 8.0-times. Daryanani expects Dell Technologies to "drift higher" on a confluence of margin expansion, better sales growth driven by share gains and resolving their storage centric challenges, and deleveraging.
01/23/19
SBSH
01/23/19
INITIATION
Target $55
SBSH
Buy
Dell Technologies initiated with a Buy at Citi
Citi analyst Jim Suva started Dell Technologies with a Buy rating and $55 price target. Consensus estimates are "missing the big boost" to net income and earnings in the second half of 2019 and beyond from Dell's future debt pay down coupled with an "attractive" valuation, Suva tells investors in a research note. The shares currently trade at a 40%-50% discount to its peers despite Dell having a much more favorable product offering, says Suva.
TEUM Pareteum
$2.37

0.05 (2.16%)

12/20/18
NORL
12/20/18
INITIATION
Target $7.5
NORL
Outperform
Pareteum initiated with an Outperform at Northland
Northland analyst Michael Latimore initiated Pareteum with an Outperform rating and $7.50 price target, stating that mobile virtual network operators, or MVNOs, are increasingly looking to SaaS platforms, such as from Pareteum, to replace on-premises software. He believes 90% of the addressable market is still served by legacy on-premises software today, Latimore noted, adding that the company's "highly experienced management team" has orchestrated a material turnaround.
01/11/19
MAXM
01/11/19
INITIATION
Target $7
MAXM
Buy
Pareteum initiated with a Buy at Maxim
Maxim analyst Allen Klee initiated Parateum with a Buy rating and a price target of $7, citing the company's position as a "one-stop shop" for outsourced "cloud" solutions for telecom service companies and enterprises. With more expected connected devices through Internet of Things technology, the analyst expects the demand for Parateum's products to remain strong. Klee is also positive on the company's efforts to clean up its balance sheet and implement a lower cost structure.
01/28/19
CHLM
01/28/19
INITIATION
Target $5
CHLM
Buy
Pareteum initiated with a Buy at Craig-Hallum
Craig-Hallum analyst George Sutton started Pareteum with a Buy rating and $5 price target, stating that the telco industry is looking for ways to add new digital services and incumbents have a structural disadvantage, which he believes opens the door for Pareteum's cloud-based offerings. He believes the growth trajectory of Pareteum is "drastically mispriced," noting that the company has historically converted greater than 100% of backlog to revenue.
11/14/18
MAXM
11/14/18
DOWNGRADE
MAXM
Hold
iPass downgraded to Hold from Buy at Maxim
Maxim analyst Allen Klee downgraded iPass (IPAS) to Hold from Buy after Pareteum (TEUM) announced an agreement to acquire iPass in an all-stock transaction.
PTE PolarityTE
$17.03

0.03 (0.18%)

01/28/19
NORL
01/28/19
INITIATION
Target $50
NORL
Outperform
PolarityTE initiated with an Outperform at Northland
As noted earlier, Northland analyst Carl Byrnes initiated PolarityTE with an Outperform and $50 price target. The analyst cites the potential of the company's first commercialized product - SkinTE - as the "only homologous autologous product that enables regeneration of full-thickness and fully functional skin." The analyst believes that the product represents a "transformational advance" that could emerge as the new standard of care for treating skin wounds with estimated peak sales potential of over $1B.
01/28/19
NORL
01/28/19
INITIATION
Target $50
NORL
Outperform
PolarityTE initiated with an Outperform at Northland
Northland analyst Carl Byrnes initiated PolarityTE with an Outperform and $50 price target.
01/28/19
NATL
01/28/19
INITIATION
Target $5
NATL
Sell
PolarityTE initiated with a Sell at National Securities
National Securities initiated PolarityTE with a Sell and $5 price target.
01/14/19
PIPR
01/14/19
NO CHANGE
PIPR
PolarityTE has 'solid momentum' heading into 2019, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren reiterated an Overweight rating and $30 price target on PolarityTE. Van Buren said that with the addition of 22 reps by year end, the company is "poised to transition the current 366 in-process accounts to active accounts and add to the 56 who are currently using the product." He also believes "data from head-to-head clinical trials will be key and expect to receive several updates throughout the year in the acute, burn and chronic wound care settings." Overall, he sees a solid amount of momentum in PolarityTE entering 2019, and believes the company is on track to achieve $300M+ in SkinTE sales by 2025.

TODAY'S FREE FLY STORIES

COP

ConocoPhillips

$53.99

-0.55 (-1.01%)

08:03
10/19/19
10/19
08:03
10/19/19
08:03
Periodicals
ConocoPhillips stock looking cheap following selloff, Barron's says »

At a time when Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 19

    Nov

AMZN

Amazon.com

$1,757.77

-30.07 (-1.68%)

, NFLX

Netflix

$275.40

-17.88 (-6.10%)

08:00
10/19/19
10/19
08:00
10/19/19
08:00
Periodicals
Comcast stacking up better than investors might expect, Barron's says »

If cord-cutting…

AMZN

Amazon.com

$1,757.77

-30.07 (-1.68%)

NFLX

Netflix

$275.40

-17.88 (-6.10%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$45.58

-0.36 (-0.78%)

T

AT&T

$38.46

0.64 (1.69%)

DIS

Disney

$130.91

-1.46 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 07

    Nov

  • 18

    Nov

  • 19

    Nov

  • 21

    Nov

AKS

AK Steel

$2.45

0.055 (2.30%)

, MT

ArcelorMittal

$14.58

0.03 (0.21%)

07:41
10/19/19
10/19
07:41
10/19/19
07:41
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AKS

AK Steel

$2.45

0.055 (2.30%)

MT

ArcelorMittal

$14.58

0.03 (0.21%)

NUE

Nucor

$51.69

-0.11 (-0.21%)

STLD

Steel Dynamics

$28.71

-0.04 (-0.14%)

TMST

TimkenSteel

$5.42

-0.015 (-0.28%)

X

U.S. Steel

$10.72

0.1 (0.94%)

GM

General Motors

$36.19

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

  • 31

    Oct

  • 01

    Nov

AAVMY

ABN Amro

$0.00

(0.00%)

, BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

04:55
10/19/19
10/19
04:55
10/19/19
04:55
Conference/Events
Institute of International Finance to hold annual meeting »

2019 IIF Annual Meeting…

AAVMY

ABN Amro

$0.00

(0.00%)

BBVA

Banco Bilbao

$5.38

0.07 (1.32%)

BCS

Barclays

$8.48

0.11 (1.31%)

BLK

BlackRock

$445.26

-5.56 (-1.23%)

BNPQY

BNP Paribas

$0.00

(0.00%)

C

Citi

$69.76

0.16 (0.23%)

CAIXY

CaixaBank

$0.00

(0.00%)

CIB

Bancolombia

$49.65

0.12 (0.24%)

CS

Credit Suisse

$12.34

0.045 (0.37%)

EV

Eaton Vance

$44.07

-0.49 (-1.10%)

GS

Goldman Sachs

$206.61

0.13 (0.06%)

HSBC

HSBC

$38.72

-0.165 (-0.42%)

JPM

JPMorgan

$120.60

0.21 (0.17%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

MCO

Moody's

$217.41

-1.33 (-0.61%)

MS

Morgan Stanley

$43.70

0.25 (0.58%)

NYT

New York Times

$29.76

0.21 (0.71%)

PYPL

PayPal

$101.25

-2.38 (-2.30%)

RBS

RBS

$6.14

0.205 (3.46%)

RY

Royal Bank of Canada

$81.49

0.38 (0.47%)

SMFG

Sumitomo Mitsui

$6.87

-0.04 (-0.58%)

SPGI

S&P Global

$250.62

-2.15 (-0.85%)

STT

State Street

$63.40

3.69 (6.18%)

UBS

UBS

$11.35

0.09 (0.80%)

V

Visa

$175.83

-2.11 (-1.19%)

ZURVY

Zurich Insurance

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 06

    Nov

  • 10

    Nov

  • 12

    Nov

  • 21

    Nov

  • 04

    Dec

  • 10

    Dec

  • 07

    Jan

  • 14

    Jan

  • 14

    Jan

STT

State Street

$63.40

3.69 (6.18%)

20:09
10/18/19
10/18
20:09
10/18/19
20:09
Upgrade
State Street rating change at Keefe Bruyette »

State Street upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SUN

Sunoco

$32.43

0.32 (1.00%)

19:53
10/18/19
10/18
19:53
10/18/19
19:53
Upgrade
Sunoco rating change at BMO Capital »

Sunoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLF

Tandy Leather

$4.61

(0.00%)

18:24
10/18/19
10/18
18:24
10/18/19
18:24
Hot Stocks
Tandy Leather CFO Castillo to step down »

Tandy Leather Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLF

Tandy Leather

$4.61

(0.00%)

18:23
10/18/19
10/18
18:23
10/18/19
18:23
Hot Stocks
Tandy Leather says most recent annual report statements not reliable »

Tandy Leather Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$236.29

0.99 (0.42%)

18:03
10/18/19
10/18
18:03
10/18/19
18:03
Hot Stocks
U.S. lawmakers request Apple restore HKMapp app in Hong Kong »

U.S. Senators Ron Wyden,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

JPM

JPMorgan

$120.60

0.21 (0.17%)

, FB

Facebook

$185.96

-4.435 (-2.33%)

17:59
10/18/19
10/18
17:59
10/18/19
17:59
Periodicals
JPMorgan CEO says Libra 'a neat idea that will never happen,' Reuters says »

JPMorgan (JPM) CEO Jamie…

JPM

JPMorgan

$120.60

0.21 (0.17%)

FB

Facebook

$185.96

-4.435 (-2.33%)

PYPL

PayPal

$101.25

-2.38 (-2.30%)

MA

MasterCard

$270.90

-5.74 (-2.07%)

V

Visa

$175.83

-2.11 (-1.19%)

EBAY

eBay

$38.82

-0.31 (-0.79%)

BKNG

Booking Holdings

$2,012.20

-16.43 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 04

    Nov

  • 21

    Nov

  • 14

    Jan

GLD

SPDR Gold Shares

$140.47

-0.13 (-0.09%)

17:52
10/18/19
10/18
17:52
10/18/19
17:52
Hot Stocks
SPDR Gold Shares holdings rise to 924.64MT from 918.19MT »

This is the first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$16.48

0.11 (0.67%)

17:43
10/18/19
10/18
17:43
10/18/19
17:43
Hot Stocks
Teck Resources gets approval for stock buyback for up to 40M class B shares »

Teck Resources has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

OSK

Oshkosh

$77.22

0.46 (0.60%)

17:41
10/18/19
10/18
17:41
10/18/19
17:41
Hot Stocks
Oshkosh awarded $159.14M Army contract for medium tactical vehicle production »

Oshkosh was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 19

    Nov

  • 20

    Nov

OVLY

Oak Valley Bancorp

$16.40

-0.16 (-0.97%)

17:35
10/18/19
10/18
17:35
10/18/19
17:35
Earnings
Oak Valley Bancorp reports Q3 EPS 40c vs. 37c last year »

Reports Q3 NII $10.4M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNW

FTE Networks

$0.79

-0.0185 (-2.29%)

17:21
10/18/19
10/18
17:21
10/18/19
17:21
Hot Stocks
FTE Networks receives noncompliance notice from NYSE American »

FTE Networks announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.45

0.0048 (1.07%)

17:12
10/18/19
10/18
17:12
10/18/19
17:12
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLMD

Relmada Therapeutics

$20.18

1.07 (5.60%)

17:10
10/18/19
10/18
17:10
10/18/19
17:10
Syndicate
Breaking Syndicate news story on Relmada Therapeutics »

Relmada Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
10/18/19
10/18
16:55
10/18/19
16:55
General news
Breaking General news story  »

Dallas Federal Reserve…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

, NWS

News Corp

$13.79

-0.11 (-0.79%)

16:51
10/18/19
10/18
16:51
10/18/19
16:51
Periodicals
Facebook reaches pact with News Corp., others for news section, WSJ says »

News Corp. (NWSA) has…

NWSA

News Corp.

$13.48

-0.19 (-1.39%)

NWS

News Corp

$13.79

-0.11 (-0.79%)

FB

Facebook

$185.96

-4.435 (-2.33%)

NYT

New York Times

$29.76

0.21 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

  • 06

    Nov

WAIR

Wesco Aircraft

$11.01

0.01 (0.09%)

16:46
10/18/19
10/18
16:46
10/18/19
16:46
Conference/Events
Wesco Aircraft to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:41
10/18/19
10/18
16:41
10/18/19
16:41
Hot Stocks
Breaking Hot Stocks news story on Foamix »

Foamix up 7.5% at $3.35…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

POAI

Predictive Oncology

$0.44

0.0101 (2.35%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Conference/Events
Predictive Oncology to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BK

BNY Mellon

$45.34

0.975 (2.20%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
BNY Mellon SVP Harris sells 50K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOMX

Foamix

$3.15

-0.09 (-2.78%)

16:40
10/18/19
10/18
16:40
10/18/19
16:40
Hot Stocks
Breaking Hot Stocks news story on Foamix 

Foamix trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 20

    Oct

BAC

Bank of America

$30.37

0.1 (0.33%)

16:35
10/18/19
10/18
16:35
10/18/19
16:35
Hot Stocks
Bank of America's Knox sells 40,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.